Skip to main content
Journal cover image

Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database.

Publication ,  Journal Article
Slaughter, MS; Badhwar, V; Ising, M; Ganzel, BL; Sell-Dottin, K; Jawitz, OK; Zhang, S; Trivedi, JR
Published in: The Journal of thoracic and cardiovascular surgery
April 2021

The incidence of intravenous drug-associated tricuspid valve endocarditis in the United States is rapidly increasing. Our goal was to evaluate the outcomes of isolated tricuspid valve operations using the Society of Thoracic Surgeon Adult Cardiac Surgical Database.From July 2011 to December 2016, 1613 patients with intravenous drug-associated tricuspid valve endocarditis underwent isolated tricuspid valve operations for endocarditis. Patients were stratified on the basis of type of tricuspid valve operation: valvectomy in 119 (7%), repair in 532 (33%), and replacement in 962 (60%). Risk factors and 30-day outcomes were compared among groups using Kruskal-Wallis and Pearson's chi-square tests. Multivariable logistic regression evaluated risk-adjusted operative mortality and morbidity by operative technique.Age, gender, race, and renal function were comparable among groups. Compared with the repair and replacement groups, the valvectomy group had a higher rate of acute infection (90% vs 79%, 84%; P < .01), Model for End-Stage Liver Disease score (10.17 vs 8.44, 9.74, P < .01), and urgent/emergency surgery (91% vs 75%, 83%; P < .01), respectively. Operative mortality was higher in those undergoing valvectomy (16%) (P < .01) compared with repair (2%) or replacement (3%). After risk adjustment, valvectomy was associated with a higher risk of operative mortality compared with repair (odds ratio, 3.82; P < .01), whereas there was no difference in operative mortality between repair and replacement (odds ratio, 0.95; P = .89).This contemporary series of intravenous drug-associated tricuspid valve endocarditis reveals that valvectomy is an independent predictor of operative mortality. When anatomically possible, repair should be the preferred management for tricuspid valve endocarditis to avoid recurrent valve infection and prosthetic valve degeneration.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The Journal of thoracic and cardiovascular surgery

DOI

EISSN

1097-685X

ISSN

0022-5223

Publication Date

April 2021

Volume

161

Issue

4

Start / End Page

1227 / 1235.e1

Related Subject Headings

  • Tricuspid Valve
  • Treatment Outcome
  • Substance Abuse, Intravenous
  • Risk Factors
  • Retrospective Studies
  • Respiratory System
  • Male
  • Humans
  • Heart Valve Diseases
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Slaughter, M. S., Badhwar, V., Ising, M., Ganzel, B. L., Sell-Dottin, K., Jawitz, O. K., … Trivedi, J. R. (2021). Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database. The Journal of Thoracic and Cardiovascular Surgery, 161(4), 1227-1235.e1. https://doi.org/10.1016/j.jtcvs.2019.10.124
Slaughter, Mark S., Vinay Badhwar, Mickey Ising, Brian L. Ganzel, Kristen Sell-Dottin, Oliver K. Jawitz, Shuaiqi Zhang, and Jaimin R. Trivedi. “Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database.The Journal of Thoracic and Cardiovascular Surgery 161, no. 4 (April 2021): 1227-1235.e1. https://doi.org/10.1016/j.jtcvs.2019.10.124.
Slaughter MS, Badhwar V, Ising M, Ganzel BL, Sell-Dottin K, Jawitz OK, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database. The Journal of thoracic and cardiovascular surgery. 2021 Apr;161(4):1227-1235.e1.
Slaughter, Mark S., et al. “Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database.The Journal of Thoracic and Cardiovascular Surgery, vol. 161, no. 4, Apr. 2021, pp. 1227-1235.e1. Epmc, doi:10.1016/j.jtcvs.2019.10.124.
Slaughter MS, Badhwar V, Ising M, Ganzel BL, Sell-Dottin K, Jawitz OK, Zhang S, Trivedi JR. Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database. The Journal of thoracic and cardiovascular surgery. 2021 Apr;161(4):1227-1235.e1.
Journal cover image

Published In

The Journal of thoracic and cardiovascular surgery

DOI

EISSN

1097-685X

ISSN

0022-5223

Publication Date

April 2021

Volume

161

Issue

4

Start / End Page

1227 / 1235.e1

Related Subject Headings

  • Tricuspid Valve
  • Treatment Outcome
  • Substance Abuse, Intravenous
  • Risk Factors
  • Retrospective Studies
  • Respiratory System
  • Male
  • Humans
  • Heart Valve Diseases
  • Female